CD8A and breast carcinoma: This non permissive status of the vasculature could be reversed by inhibition of endothelial DNA methyltransferase 1, promoting CD8+ T lymphocytes recruitment and potentiating the efficacy of immune checkpoint inhibitors in breast cancer mouse models.[80]